Raymond James & Associates’s Humana HUM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | $31.5M | Buy |
99,530
+3,341
| +3% | +$1.19M | 0.02% | 604 |
|
|
2024
Q2 | $35.9M | Buy |
96,189
+4,757
| +5% | +$1.61M | 0.02% | 524 |
|
|
2024
Q1 | $31.7M | Sell |
91,432
-9,819
| -10% | -$3.72M | 0.02% | 573 |
|
|
2023
Q4 | $46.4M | Buy |
101,251
+22,550
| +29% | +$11.1M | 0.03% | 410 |
|
|
2023
Q3 | $38.3M | Sell |
78,701
-55,802
| -41% | -$26.2M | 0.03% | 433 |
|
|
2023
Q2 | $60.1M | Buy |
134,503
+10,746
| +9% | +$5.41M | 0.05% | 319 |
|
|
2023
Q1 | $60.1M | Sell |
123,757
-2,184
| -2% | -$1.08M | 0.05% | 309 |
|
|
2022
Q4 | $64.5M | Buy |
125,941
+15,634
| +14% | +$8.22M | 0.06% | 281 |
|
|
2022
Q3 | $53.5M | Buy |
110,307
+4,742
| +4% | +$2.31M | 0.05% | 301 |
|
|
2022
Q2 | $49.4M | Buy |
105,565
+5,011
| +5% | +$2.23M | 0.05% | 323 |
|
|
2022
Q1 | $43.8M | Buy |
100,554
+114
| +0.1% | +$47.7K | 0.04% | 398 |
|
|
2021
Q4 | $46.6M | Buy |
100,440
+5,629
| +6% | +$2.49M | 0.04% | 408 |
|
|
2021
Q3 | $36.9M | Buy |
94,811
+10,553
| +13% | +$4.48M | 0.03% | 447 |
|
|
2021
Q2 | $37.3M | Buy |
84,258
+3,229
| +4% | +$1.41M | 0.03% | 444 |
|
|
2021
Q1 | $34M | Buy |
81,029
+30,316
| +60% | +$12.1M | 0.03% | 438 |
|
|
2020
Q4 | $20.8M | Sell |
50,713
-13,540
| -21% | -$5.63M | 0.02% | 600 |
|
|
2020
Q3 | $26.6M | Buy |
64,253
+2,108
| +3% | +$848K | 0.03% | 442 |
|
|
2020
Q2 | $24.1M | Sell |
62,145
-895
| -1% | -$335K | 0.03% | 456 |
|
|
2020
Q1 | $19.8M | Sell |
63,040
-9,742
| -13% | -$3.29M | 0.03% | 457 |
|
|
2019
Q4 | $26.7M | Sell |
72,782
-4,621
| -6% | -$1.47M | 0.03% | 460 |
|
|
2019
Q3 | $19.8M | Buy |
77,403
+13,483
| +21% | +$3.78M | 0.03% | 546 |
|
|
2019
Q2 | $17M | Buy |
63,920
+19,741
| +45% | +$5.01M | 0.02% | 602 |
|
|
2019
Q1 | $11.8M | Sell |
44,179
-20,398
| -32% | -$5.88M | 0.02% | 729 |
|
|
2018
Q4 | $18.5M | Buy |
64,577
+9,679
| +18% | +$3.07M | 0.03% | 502 |
|
|
2018
Q3 | $18.6M | Buy |
54,898
+17,133
| +45% | +$5.57M | 0.03% | 564 |
|
|
2018
Q2 | $11.2M | Buy |
37,765
+9,820
| +35% | +$2.88M | 0.02% | 751 |
|
|
2018
Q1 | $7.51M | Buy |
27,945
+1,372
| +5% | +$371K | 0.01% | 927 |
|
|
2017
Q4 | $6.59M | Buy |
26,573
+4,342
| +20% | +$1.07M | 0.01% | 979 |
|
|
2017
Q3 | $5.42M | Buy |
22,231
+6,031
| +37% | +$1.48M | 0.01% | 1042 |
|
|
2017
Q2 | $3.9M | Buy |
16,200
+782
| +5% | +$177K | 0.01% | 1152 |
|
|
2017
Q1 | $3.18M | Sell |
15,418
-7,299
| -32% | -$1.51M | 0.01% | 1253 |
|
|
2016
Q4 | $4.63M | Buy |
22,717
+8,657
| +62% | +$1.65M | 0.01% | 1029 |
|
|
2016
Q3 | $2.49M | Sell |
14,060
-39
| -0.3% | -$6.77K | 0.01% | 1329 |
|
|
2016
Q2 | $2.54M | Sell |
14,099
-3,386
| -19% | -$601K | 0.01% | 1205 |
|
|
2016
Q1 | $3.2M | Buy |
17,485
+2,597
| +17% | +$451K | 0.01% | 1045 |
|
|
2015
Q4 | $2.66M | Sell |
14,888
-990
| -6% | -$174K | 0.01% | 1110 |
|
|
2015
Q3 | $2.84M | Sell |
15,878
-1,647
| -9% | -$304K | 0.01% | 1028 |
|
|
2015
Q2 | $3.35M | Buy |
17,525
+263
| +2% | +$48.8K | 0.01% | 1030 |
|
|
2015
Q1 | $3.07M | Buy |
17,262
+967
| +6% | +$153K | 0.01% | 989 |
|
|
2014
Q4 | $2.34M | Buy |
+16,295
| New | +$2.23M | 0.01% | 1072 |
|
|
2013
Q3 | – | Sell |
-44,750
| Closed | -$3.78M | – | 1934 |
|
|
2013
Q2 | $3.78M | Buy |
+44,750
| New | +$3.53M | 0.04% | 536 |
|
Other funds holding HUM
Raymond James & Associates's HUM Position: Q3 2024 in Review
Raymond James & Associates increased its Humana (HUM) stake by 3.5% in Q3 2024, buying an estimated $1.19M and bringing the position to 99,530 shares worth $31.5M. The position accounts for 0.02% of the portfolio, ranked #604.
Raymond James & Associates first reported a position in HUM in Q2 2013 and has held it in 41 quarters since. The position peaked at $64.5M in Q4 2022. 940 funds tracked by Wall St. Rank hold HUM as of Q3 2024.
- Raymond James & Associates held 99,530 shares of Humana worth $31.5M as of Q3 2024.
- Raymond James & Associates bought 3,341 Humana shares in Q3 2024, an estimated $1.19M.
- Humana made up 0.02% of Raymond James & Associates's portfolio in Q3 2024, its #604 holding.
- Raymond James & Associates first reported a position in Humana in Q2 2013 and has held it in 41 quarters since.
- Raymond James & Associates's Humana position peaked at $64.5M in Q4 2022.
- 940 funds tracked by Wall St. Rank held Humana as of Q3 2024.
Based on Raymond James & Associates's 13F filing for Q3 2024, filed 18 Oct 2024.